Incannex Healthcare Ltd ADR is a leading innovator in the medicinal cannabinoid sector, based in Sydney, Australia. The company is dedicated to the research and development of cannabinoid-based therapies targeting significant unmet medical needs, supported by a strong pipeline of clinical programs. With a focus on regulatory compliance and a strategic commercialization approach, Incannex is well-positioned to capitalize on the growing demand for evidence-based therapeutic products, reinforcing its status as a key player in the evolving healthcare market. Show more
Location: 8 CENTURY CIRCUIT, SYDNEY, NSW, AUSTRALIA, 2153, Sydney, NSW, 2153, USA | Website: https://www.incannex.com | Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC | Sector: HEALTHCARE
Market Cap
86.56M
52 Wk Range
$0.08 - $2.09
Previous Close
$0.25
Open
$0.26
Volume
8,607,494
Day Range
$0.26 - $0.30
Enterprise Value
24.39M
Cash
73.28M
Avg Qtr Burn
-9.163M
Insider Ownership
12.79%
Institutional Own.
0.99%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
IHL-42X Details Obstructive sleep apnoea (OSA) | Phase 2 Update | |
PSX-001 (Psi-GAD) Details Generalised Anxiety Disorder (GAD) | Phase 2 Update |
